Rocket Doctor AI Earnings Call Transcripts
Fiscal Year 2026
-
U.S. expansion reached 24M covered lives, with 3,900 completed Q2 visits and 3,600 visits in Q3’s first two months. Credentialing and payer reimbursement create a multi-month lag before revenue recognition; value-based contracts add recurring member payments.
-
The platform combines proprietary clinical AI, clinician tools, and patient access, with U.S. expansion across three states and 21M+ in-network lives. Latest-quarter revenue was cited at CAD 750,000 with 75% gross margins, alongside rapid U.S. visit growth.
-
The platform combines curated clinical AI, physician practice infrastructure and payer access, with U.S. patient visits rising from March to April 2026 and a substantial physician pipeline in credentialing. Management plans continued organic growth and further U.S. state expansion.